Recruiting
A Study to Evaluate the Drug Levels, Efficacy and Safety of BMS-986165 in Adolescent Participants With Moderate to Severe Plaque Psoriasis - IM011-126
Aggiornato:
5 giugno, 2026
|
ClinicalTrials.gov.
Stampi il riassunto semplice
Dettagli della sperimentazione
-
Phase 3
Fase
-
Sesso
-
4-18
Fascia d'età
-
36
Sede/i
-
Recruiting
Opzioni di trattamento
Principali criteri di idoneità
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: - Males and females aged 12 to <18 years - Plaque psoriasis for at least 6 months - Moderate to severe disease - Candidate for phototherapy or systemic therapy Exclusion Criteria: - Weighing ≤ 30.0 kg at screening - Other forms of psoriasis - History of recent infection - Prior exposure to BMS-986165 or active comparator Other protocol-defined inclusion/exclusion criteria apply